-
Signature
-
/s/ Holly Youngwood under POA
-
Stock symbol
-
JPM
-
Transactions as of
-
Jan 13, 2024
-
Transactions value $
-
-$2,984,713
-
Form type
-
4
-
Date filed
-
1/16/2024, 07:10 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
JPM |
Common Stock |
Options Exercise |
$0 |
+14K |
+4.88% |
$0.00 |
300K |
Jan 13, 2024 |
Direct |
F1 |
transaction |
JPM |
Common Stock |
Options Exercise |
$0 |
+13.2K |
+4.42% |
$0.00 |
313K |
Jan 13, 2024 |
Direct |
F1 |
transaction |
JPM |
Common Stock |
Tax liability |
-$2.44M |
-14.1K |
-4.51% |
$172.61 |
299K |
Jan 13, 2024 |
Direct |
|
transaction |
JPM |
Common Stock |
Sale |
-$545K |
-3.27K |
-1.09% |
$166.70 |
296K |
Jan 16, 2024 |
Direct |
|
holding |
JPM |
Common Stock |
|
|
|
|
|
23.7K |
Jan 13, 2024 |
By Family Trust |
|
holding |
JPM |
Common Stock |
|
|
|
|
|
93.8K |
Jan 13, 2024 |
By GRATs |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
JPM |
Restricted Stock Units |
Options Exercise |
$0 |
-13.2K |
-100% |
$0.00* |
0 |
Jan 13, 2024 |
Common Stock |
13.2K |
|
Direct |
F1, F2 |
transaction |
JPM |
Restricted Stock Units |
Options Exercise |
$0 |
-14K |
-50% |
$0.00 |
14K |
Jan 13, 2024 |
Common Stock |
14K |
|
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: